Login to Your Account

Alkermes, Reliant Agree On Mutual Termination' Of Merger

By Brady Huggett

Thursday, August 15, 2002
In a market that is fiercely devaluing companies and following a deflating non-approvable letter from the FDA for Risperdal, Alkermes Inc. said after the markets closed it and Reliant Pharmaceuticals LLC are nixing their planned merger that was valued at $934 million when it was announced in March. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription